IOL CHEMICALS & PHARM. | SEQUENT SCIENTIFIC | IOL CHEMICALS & PHARM./ SEQUENT SCIENTIFIC |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | -23.3 | - | View Chart |
P/BV | x | 1.4 | 4.5 | 31.4% | View Chart |
Dividend Yield | % | 1.1 | 0.0 | - |
IOL CHEMICALS & PHARM. SEQUENT SCIENTIFIC |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SEQUENT SCIENTIFIC Mar-23 |
IOL CHEMICALS & PHARM./ SEQUENT SCIENTIFIC |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 156 | 344.3% | |
Low | Rs | 272 | 62 | 440.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 57.0 | 662.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | -4.9 | -484.6% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -2.7 | -1,187.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 25.8 | 997.0% | |
Shares outstanding (eoy) | m | 58.71 | 249.43 | 23.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.9 | 56.0% | |
Avg P/E ratio | x | 17.1 | -22.3 | -76.7% | |
P/CF ratio (eoy) | x | 12.8 | -41.0 | -31.3% | |
Price / Book Value ratio | x | 1.6 | 4.2 | 37.3% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 27,151 | 87.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 2,584 | 65.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 14,209 | 156.0% | |
Other income | Rs m | 256 | 64 | 400.8% | |
Total revenues | Rs m | 22,427 | 14,273 | 157.1% | |
Gross profit | Rs m | 2,257 | -528 | -427.1% | |
Depreciation | Rs m | 462 | 557 | 82.9% | |
Interest | Rs m | 165 | 355 | 46.4% | |
Profit before tax | Rs m | 1,887 | -1,377 | -137.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -157 | -315.7% | |
Profit after tax | Rs m | 1,391 | -1,220 | -114.1% | |
Gross profit margin | % | 10.2 | -3.7 | -273.7% | |
Effective tax rate | % | 26.2 | 11.4 | 230.4% | |
Net profit margin | % | 6.3 | -8.6 | -73.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 8,125 | 119.0% | |
Current liabilities | Rs m | 5,025 | 5,588 | 89.9% | |
Net working cap to sales | % | 20.9 | 17.9 | 117.2% | |
Current ratio | x | 1.9 | 1.5 | 132.3% | |
Inventory Days | Days | 43 | 21 | 203.1% | |
Debtors Days | Days | 8 | 88 | 9.5% | |
Net fixed assets | Rs m | 11,017 | 7,435 | 148.2% | |
Share capital | Rs m | 587 | 499 | 117.7% | |
"Free" reserves | Rs m | 14,490 | 5,926 | 244.5% | |
Net worth | Rs m | 15,077 | 6,425 | 234.7% | |
Long term debt | Rs m | 0 | 1,828 | 0.0% | |
Total assets | Rs m | 20,684 | 15,661 | 132.1% | |
Interest coverage | x | 12.5 | -2.9 | -433.1% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.9 | 118.1% | |
Return on assets | % | 7.5 | -5.5 | -136.3% | |
Return on equity | % | 9.2 | -19.0 | -48.6% | |
Return on capital | % | 13.6 | -12.4 | -109.9% | |
Exports to sales | % | 26.7 | 1.8 | 1,490.9% | |
Imports to sales | % | 0 | 1.0 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 255 | 2,326.3% | |
Imports (cif) | Rs m | NA | 138 | 0.0% | |
Fx inflow | Rs m | 5,930 | 255 | 2,326.3% | |
Fx outflow | Rs m | 6,052 | 138 | 4,380.0% | |
Net fx | Rs m | -122 | 117 | -104.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 168 | 727.5% | |
From Investments | Rs m | -1,200 | -650 | 184.7% | |
From Financial Activity | Rs m | -41 | 322 | -12.8% | |
Net Cashflow | Rs m | -18 | -159 | 11.6% |
Indian Promoters | % | 48.2 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 52.8 | - | |
Indian inst/Mut Fund | % | 2.5 | 13.3 | 19.0% | |
FIIs | % | 2.2 | 6.1 | 35.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 47.2 | 109.7% | |
Shareholders | 134,235 | 172,853 | 77.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SEQUENT SCIENTIFIC | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | -3.72% | 1.18% |
1-Month | -9.26% | -12.68% | -0.75% |
1-Year | 29.97% | 70.74% | 61.82% |
3-Year CAGR | -13.41% | -21.73% | 18.16% |
5-Year CAGR | 13.41% | 9.54% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SEQUENT SCIENTIFIC share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SEQUENT SCIENTIFIC the stake stands at 52.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SEQUENT SCIENTIFIC.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SEQUENT SCIENTIFIC paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SEQUENT SCIENTIFIC.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.